Effects of Milk Fat Globule Membrane (MFGM) - Enriched Formula With Reduced Energy and Protein Content on Growth and Development
TUMME
Double-blinded Interventional Study on the Effects of MFGM-enriched Formula With Reduced Energy and Protein Content on Growth and Development
1 other identifier
interventional
240
1 country
1
Brief Summary
Formula-fed infants differ from breast-fed infants in the growth pattern, risk for obesity and cardiovascular diseases, neurological development and morbidity in infections. The investigators' hypothesis is that a modified formula with reduced energy and protein content and enrichment with Milk Fat Globule Membrane (MFGM) containing bioactive proteins and phospholipids will reduce the difference between formula-fed and breast-fed infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2008
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 15, 2008
CompletedFirst Posted
Study publicly available on registry
February 27, 2008
CompletedStudy Start
First participant enrolled
March 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2018
CompletedNovember 17, 2020
November 1, 2020
5 years
February 15, 2008
November 13, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Body composition
Pletysmography (% body fat)
4 months
Secondary Outcomes (1)
Neurological development
1 year
Other Outcomes (1)
Neurological development
6.5 years
Study Arms (3)
1
EXPERIMENTALModified formula
2
NO INTERVENTIONStandard formula
3
NO INTERVENTIONBreastfed
Interventions
MFGM-enriched formula with reduced energy and protein content
Eligibility Criteria
You may qualify if:
- Term infants with birth weight 2500-4500 gr
- Fed with breastmilk only or formula only before 2 months of age
You may not qualify if:
- Chronic illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Umeå Universitylead
Study Sites (1)
Dept of clinical sciences, pediatrics, Umeå University
Umeå, SE-90185, Sweden
Related Publications (2)
Timby N, Hernell O, Vaarala O, Melin M, Lonnerdal B, Domellof M. Infections in infants fed formula supplemented with bovine milk fat globule membranes. J Pediatr Gastroenterol Nutr. 2015 Mar;60(3):384-9. doi: 10.1097/MPG.0000000000000624.
PMID: 25714582DERIVEDTimby N, Domellof E, Hernell O, Lonnerdal B, Domellof M. Neurodevelopment, nutrition, and growth until 12 mo of age in infants fed a low-energy, low-protein formula supplemented with bovine milk fat globule membranes: a randomized controlled trial. Am J Clin Nutr. 2014 Apr;99(4):860-8. doi: 10.3945/ajcn.113.064295. Epub 2014 Feb 5.
PMID: 24500150DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D, Researcher
Study Record Dates
First Submitted
February 15, 2008
First Posted
February 27, 2008
Study Start
March 1, 2008
Primary Completion
March 1, 2013
Study Completion
November 1, 2018
Last Updated
November 17, 2020
Record last verified: 2020-11